Lifestyle - Page 2

Eli Lilly’s stock soared by 2.6% amid market challenges, driven by strategic decisions. The acquisition of Organovo’s FXR program positions Lilly to address ulcerative colitis and MASH. Innovations like tirzepatide medication, Zepbound, demonstrate Lilly’s competitive pricing strategy. Zepbound pricing at $349 and

Manufactured home communities offer 25% more space and cost half as much per square foot compared to average rentals, providing affordable housing solutions. Sun Communities is a leading player in the manufactured housing sector, delivering a 12.6% annualized return for investors. Despite

Vanguard’s funds are a popular choice for retirement planning among millennials and Baby Boomers, providing security and growth potential. The urgent need for early retirement planning is highlighted, particularly as many rely on employer-sponsored contributions, which are unevenly distributed. The top 20%

Precision BioSciences introduced PBGENE-HBV, a gene-editing treatment for chronic Hepatitis B, through the ELIMINATE-B trial. The trial began with three participants receiving the lowest dose, showing promising safety results without severe reactions. Initial results from two participants indicated a reduction in Hepatitis